Mather's Pharm. Co., Ltd.
Clinical trials sponsored by Mather's Pharm. Co., Ltd., explained in plain language.
-
New gastritis pill faces off against standard treatment in 470-Patient trial
Disease control Not yet recruitingThis study tests whether a new tablet called Sto M Tab. works as well as the standard treatment Stillen Tab. for people with acute or chronic gastritis (stomach lining inflammation). About 470 adults aged 19-75 will take one of the two tablets for 2 weeks. The main goal is to see…
Phase: PHASE4 • Sponsor: Mather's Pharm. Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 13:02 UTC
-
New pill aims to ease knee pain without being worse than current drug
Symptom relief Not yet recruitingThis study tests whether a new tablet called Laybon is as good as an existing drug (Layla) at reducing knee pain from osteoarthritis. About 172 adults aged 40-80 with knee osteoarthritis will take either Laybon or Layla twice daily for 8 weeks. The main goal is to see if knee pai…
Phase: PHASE4 • Sponsor: Mather's Pharm. Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:52 UTC
-
New bowel prep pill could make colonoscopies easier
Symptom relief Not yet recruitingThis study tests a new tablet called MSP01-T for cleaning the bowel before a colonoscopy. About 214 adults will be randomly assigned to take either the new tablet or a standard bowel prep. The goal is to see if the new tablet works just as well and is safe.
Phase: PHASE3 • Sponsor: Mather's Pharm. Co., Ltd. • Aim: Symptom relief
Last updated Jun 27, 2026 07:51 UTC